Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Juvenile hemochromatosis.

Clara Camaschella1, Antonella Roetto, Marco De Gobbi

  • 1Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.

Seminars in Hematology
|October 17, 2002
PubMed
Summary

Juvenile hemochromatosis causes severe iron overload in children, leading to early hypogonadism and cardiac issues. This rare genetic disorder, mapping to chromosome 1q21, is fatal if untreated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term outcomes of autologous haematopoietic stem cell transplantation in multiple sclerosis: A retrospective single-centre experience.

Multiple sclerosis journal - experimental, translational and clinical·2026
Same author

Clinical Outcomes of Ruxolitinib Treatment in Patients With IPSS Intermediate-1-Risk Myelofibrosis: Interim Analysis From an Italian, Prospective Study (ROMEI).

Hematological oncology·2026
Same author

Characterization of ferroportin disease and SLC40A1-related hemochromatosis - Results from the EASL non-HFE registry.

Journal of hepatology·2026
Same author

Treatment of Acute Myeloid Leukemias and Myelodisplastic Syndromes Relapsing After Allogeneic Stem Cell Transplantation: An In-Depth Analysis of the GITMO AML/MDS-Relapse Registry Study.

Clinical lymphoma, myeloma & leukemia·2026
Same author

GB2064 (lenumlostat) shows preliminary evidence of bone marrow collagen fibrosis reduction with manageable tolerability in JAK inhibitor-refractory myelofibrosis: results from the MYLOX-1 phase IIa study.

Haematologica·2026
Same author

Tips and tricks in cryopreservation of hematopoietic stem cells: critical points to keep under control.

Cytotherapy·2026

Area of Science:

  • Genetics
  • Hematology
  • Pediatrics

Background:

  • Juvenile hemochromatosis (type 2) is a rare, inherited disorder causing early-onset iron overload.
  • It presents distinctively from HFE-related hemochromatosis with more severe, earlier manifestations.

Purpose of the Study:

  • To describe the clinical and genetic characteristics of juvenile hemochromatosis.
  • To highlight the critical role of the yet-unidentified gene in iron homeostasis.

Main Methods:

  • Review of clinical data from patients with juvenile hemochromatosis.
  • Genetic linkage analysis to map the disease locus to chromosome 1q21.

Main Results:

  • Early childhood signs include elevated transferrin saturation, serum ferritin, and liver iron deposition.
  • Symptoms like hypogonadism and cardiac disease manifest before age 30.
  • The disease locus is confirmed at chromosome 1q21.

Conclusions:

  • Juvenile hemochromatosis is a severe, progressive condition requiring early diagnosis and management.
  • The gene responsible for type 2 hemochromatosis plays a vital role in regulating iron balance.
  • Untreated disease can lead to fatal heart failure.

Related Experiment Videos